Company Filing History:
Years Active: 2018-2020
Title: Laure De Parseval: Innovator in Combination Therapy
Introduction
Laure De Parseval is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of medicine, particularly in the area of cancer treatment. With a focus on combination therapies, her work aims to overcome resistance to existing treatments.
Latest Patents
Laure De Parseval holds 2 patents related to her innovative approaches in treating proliferative diseases. Her latest patents involve a combination therapy that reverses resistance to a B-Raf inhibitor. This therapy includes obtaining a tumor sample from the patient and testing it for genetic alterations in a comprehensive panel of genes. The identified alterations guide the administration of a drug combination therapy that includes the B-Raf inhibitor and a second inhibitor, specifically chosen based on the genetic findings.
Career Highlights
Throughout her career, Laure has worked with leading pharmaceutical companies, including Novartis AG and Array Biopharma Inc. Her expertise in the field has positioned her as a key player in the development of effective cancer therapies.
Collaborations
Laure has collaborated with notable professionals in her field, including Giordano Caponigro and Darrin Stuart. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Laure De Parseval's work exemplifies the impact of innovative thinking in the medical field. Her dedication to developing effective combination therapies continues to pave the way for advancements in cancer treatment.